1. Home
  2. OTLK vs BEATW Comparison

OTLK vs BEATW Comparison

Compare OTLK & BEATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OTLK
  • BEATW
  • Stock Information
  • Founded
  • OTLK 2010
  • BEATW 2015
  • Country
  • OTLK United States
  • BEATW United States
  • Employees
  • OTLK N/A
  • BEATW 21
  • Industry
  • OTLK Biotechnology: Biological Products (No Diagnostic Substances)
  • BEATW Retail: Computer Software & Peripheral Equipment
  • Sector
  • OTLK Health Care
  • BEATW Technology
  • Exchange
  • OTLK Nasdaq
  • BEATW Nasdaq
  • Market Cap
  • OTLK N/A
  • BEATW N/A
  • IPO Year
  • OTLK 2016
  • BEATW N/A
  • Fundamental
  • Price
  • OTLK $1.45
  • BEATW N/A
  • Analyst Decision
  • OTLK Strong Buy
  • BEATW
  • Analyst Count
  • OTLK 5
  • BEATW 0
  • Target Price
  • OTLK $10.20
  • BEATW N/A
  • AVG Volume (30 Days)
  • OTLK 448.0K
  • BEATW 4.7K
  • Earning Date
  • OTLK 05-14-2025
  • BEATW 03-14-2025
  • Dividend Yield
  • OTLK N/A
  • BEATW N/A
  • EPS Growth
  • OTLK N/A
  • BEATW N/A
  • EPS
  • OTLK N/A
  • BEATW N/A
  • Revenue
  • OTLK N/A
  • BEATW N/A
  • Revenue This Year
  • OTLK N/A
  • BEATW N/A
  • Revenue Next Year
  • OTLK $288.46
  • BEATW N/A
  • P/E Ratio
  • OTLK N/A
  • BEATW N/A
  • Revenue Growth
  • OTLK N/A
  • BEATW N/A
  • 52 Week Low
  • OTLK $0.87
  • BEATW $0.50
  • 52 Week High
  • OTLK $9.29
  • BEATW $0.62
  • Technical
  • Relative Strength Index (RSI)
  • OTLK 55.83
  • BEATW N/A
  • Support Level
  • OTLK $1.30
  • BEATW N/A
  • Resistance Level
  • OTLK $1.46
  • BEATW N/A
  • Average True Range (ATR)
  • OTLK 0.13
  • BEATW 0.00
  • MACD
  • OTLK 0.04
  • BEATW 0.00
  • Stochastic Oscillator
  • OTLK 90.70
  • BEATW 0.00

About BEATW Heartbeam Inc.

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

Share on Social Networks: